8-KFinancial EventsOther EventsExhibits & Filings

Elevance Health, Inc. 8-K Report, Financial Obligation (Feb 5, 2009)

Filed February 5, 2009For Securities:ELV

Summary

Elevance Health, Inc. (formerly WellPoint, Inc.) reported on February 5, 2009, the successful closing of a significant debt offering totaling $1 billion. This offering consisted of $400 million in 6.000% Notes due 2014 and $600 million in 7.000% Notes due 2019. The net proceeds, approximately $990.3 million after deducting underwriting discounts and expenses, are earmarked for working capital and general corporate purposes, including potential repayment of short-term debt and share repurchases. This debt issuance provides the company with substantial liquidity to support its ongoing operations and strategic initiatives. The terms of the notes include semi-annual interest payments and maturity dates in 2014 and 2019, respectively. Importantly, the indenture does not restrict the company from incurring additional indebtedness. Provisions are in place for events of default and a potential change of control that could trigger a mandatory purchase offer to noteholders.

Key Highlights

  • 1Completed a $1 billion debt offering consisting of 6.000% Notes due 2014 ($400 million) and 7.000% Notes due 2019 ($600 million).
  • 2Net proceeds of approximately $990.3 million received from the offering.
  • 3Proceeds intended for working capital and general corporate purposes, including debt repayment and share repurchases.
  • 4Interest on the notes is payable semi-annually on February 15 and August 15.
  • 5Notes mature on February 15, 2014 (2014 Notes) and February 15, 2019 (2019 Notes).
  • 6The indenture permits the company to incur additional indebtedness.
  • 7A 'change of control' event, coupled with a credit rating downgrade, may trigger a mandatory repurchase offer for the notes.

Frequently Asked Questions

The company issued these notes to raise capital for working capital and general corporate purposes. This includes potential repayment of short-term debt and the repurchase of the company's common stock, providing financial flexibility.

The offering includes $400 million of 6.000% Notes due February 15, 2014, and $600 million of 7.000% Notes due February 15, 2019. Interest is paid semi-annually.

Based on the filing, the Indenture governing these notes does not prohibit or limit the company or its subsidiaries from incurring additional indebtedness and other liabilities.

If a change of control occurs and the notes are downgraded below investment grade by major rating agencies (Moody's, S&P, Fitch) within a specified period, the company will be required to make an offer to purchase all of the outstanding notes at 101% of their principal amount, plus accrued interest.